Buck has been awarded $12.7 million to join SenNet, the NIH-supported #CellularSenescence Network. Our scientists will identify and characterize senescent cells, recognized as driver of age-related disease in human ovaries, breast tissue & skeletal muscle https://t.co/xAWkWtQIXv
So excited to share our latest research on improving intestinal barrier dysfunction using a set of compounds called S3QELs (Suppressors of IIIQo electron leak in mitochondria) that result in an increase in median lifespan.
https://t.co/xC07MJcTAy
Read all the way to the end to get some great insights on leaky gut syndrome from Dr. Mark Watson representing a certain institute for research on aging you might have heard of… #livebetterlonger https://t.co/gN1T3k3Djp
Our lab’s mini review on the “Use of S1QELs and S3QELs to link mitochondrial sites of superoxide and hydrogen peroxide generation to physiological and pathological outcomes”. These compounds were originally founded at @BuckInstitute by the Brand lab. https://t.co/026rXBo3Gr